Blue Horseshoe Stocks: AVNR, SINO, FREE & More

Avanir Pharmaceuticals, Inc. AVNR

We included AVNR in our extended watchlist yesterday and we were glad that we did. The company released an announcement concerning the positive clinical trials of its drug “AVP-923” which is used to treat Alzheimer’s >>Read The Release and what followed was one heck of a bullish session.

The stock saw an early low of 9.32, and steadily pushed its way up all session long, with the high of 13.09 coming just prior to the close. That mark represented a solid 40% intraday gain, as well as a new 52-week high! The amount of volume traded was also impressive, on the order of more than 89M shares, an annual record and more than 25X the three-month average, so we really like the timing of our alert on AVNR.

AVNR provides another good example of why we always remind our subscribers to check through our daily extended watchlist selections thoroughly, as hidden gems like this one tend to pop up with surprising regularity.


Sino-Global Shipping America Ltd. SINO

SINO began to run when the company released financials that included some significant highlights just prior to the close yesterday, and the stock is gapping up heavily this morning for what should be an interesting session.

Generally in these instances we’ll be on the lookout for the phenomenon we refer to as the dip-and-rip. Stockholders see the huge run, and the resultant profit-taking usually leads to a subsequent pullback. That’s where we’re waiting to catch the bounce and snipe some rapid profits.


FreeSeas Inc. FREE

FREE made its way down to a new 52-week low of .29 yesterday and could be in prime position for a possible bounceplay. This morning, the company has revealed that it has concluded the sale of one of its vessels for $12.25M and entered into a long-term charter with the new owners >> View PR

FREE is gapping up as a result and provided that the stock can break through resistance at roughly .45 which we’ve pointed out on the following chart, things could get very interesting.


Options Trading Ideas

We’ve got a couple of possibilities we’re looking at in the options arena today as well:

– RWLK $38-$40 Calls

– PBR $16.50 & $17 Calls


Extended Watchlist:
GRT, NWBO, DNDN, MSTX, STRI

Blue Horseshoe Stocks: APPG, RSH & OTIV Updates

Apptigo International, Inc. APPG

Our readers may recall that we tagged APPG as a potential bottom-play in Friday’s premarket report, as the stock was coming off its 52-week lows a couple of sessions prior.

We mentioned that we liked APPG “provided it can hold support above .365 in order to break the pattern of its recent downtrend”, and it did in fact maintain support above that level. We saw a daily range from .37-.43 which is equal to a 16% move, and the stock closed just a penny below its high-of-day.

We’ll be monitoring APPG as we kick off a new trading week, and looking for the stock to register higher lows and higher highs to confirm a sustained uptrend.


RadioShack Corp. RSH

Despite recent uncertainty caused by talk of possible bankruptcy proceedings, RSH did well on Friday. We’ve been tracking the stock heavily since the beginning of August, where we caught it at its 52-week low of .55.

Following a gradual incline to a high of 1.77, the stock has been under recent consolidation, and toward the end of last week we were looking for it to maintain support above its then-50DMA of .83, and it did just that.

On Friday it traded in a daily range from .86-1.00 (+16%), and closed at .91. Like the previously mentioned stock we’ll need to see RSH record higher lows and higher highs, and test its next key areas of resistance at 1.15 and 1.30.

It should go without saying that we’ll also want to keep our ear to the tracks for updates on RSH’s tenuous financial situation.


On Track Innovations Ltd. OTIV

OTIV made an appearance in Thursday’s newsletter on our extended watchlist. We saw the stock touch a low of 3.12 that morning, and then begin a gradual ascent spanning through Friday’s session as it went on to a subsequent high of 3.94 (+26%).

It’s going to remain high on watchlist today, as we’ve already seen trades in the premarket going off as high as 4.39. At that level, our total possible gain on this stock over the course of just a few sessions is expanded to 41%


Extended Watchlist:
AVNR, HALO, TWGP, API, MILL, NVFY

Blue Horseshoe Stocks: PBR, ACHN, TMSH & More

Petroleo Brasiliero S.A. (Petrobras) PBR

We’ll kick things off this morning with PBR once again, as the stock had another banner day and behaved very much like we suggested it might. Yesterday we mentioned that the PBR chart was looking ripe for further northward movement and that’s just what we got.

The stock itself broke back over $15, which led to some prime opportunities in each and every set of options contracts that we outlined in our morning report. We said we’d be looking at Weekly Calls from $14-$15 for quick-flip intraday opportunities, and they all offered up some serious gains.

The $14 Calls traded from .74 to as high as 1.09, a chance for traders to score up to 47% in profits. The $14.50’s made a nice move up from .34 to .75, good for a nice double-bagger and more at +120% The $15’s fared extremely well also, running a whopping 290% from .11 up to .43.

Even our contracts of longer-term interest, the 07/19 $15 Calls (which we caught at a low of .25) made a solid intraday move from .54-.84, a highly respectable 55% increase.

All in all, for options traders, PBR was a paradise on Monday, and we’ll be continuously monitoring the situation as the week progresses. Major areas of resistance appear on the chart at 15.50 and 15.85, so failure to pierce through that channel would certainly be a signal to us to take profits off of the table. In order to keep our interest levels high, PBR will need to maintain support above the 15-dollar mark.


Achillion Pharmaceuticals, Inc. ACHN

Appearing in yesterday’s extended watchlist, ACHN was another play with potential to start off a new week. After a significant morning gap-up, the stock would touch a low of 3.72 before running as high as 4.82, an intraday move of 30%

This morning the company came with a well-timed release concerning its Hep-C drug, and the stock continues to blow its top. The high this morning in premarket trading is 6.47, making ACHN one that we’ll definitely be interested to follow. Per this morning’s PR, there’s a timeline for the testing of this drug leading all the way up to the end of the year, so we’ll stick ACHN on our longer-term radar as well.

NEW HAVEN, Jun 10, 2014 (GLOBE NEWSWIRE via COMTEX) — Initial cohort of HCV-infected patients begin dosing with ACH-3422 for seven days. Clinical trials may continue evaluating 200 mg of sovaprevir for HCV-infected patients. Timelines for reporting proof-of-concept results with ACH-3422, a proprietary uridine-analog nucleotide polymerase inhibitor, during the fall of 2014 and initiating all-oral combination studies by the end of 2014 remain on track >>> FULL PR


TransGlobal Assets, Inc. TMSH

We’ve been following TMSH since last week, and have not been disappointed. The stock has played out a textbook dip-and-rip scenario for the last three sessions straight, offering up many opportunities to make gains.

Yesterday, it came down as low as .0079 before ripping its way up to .0128, a healthy intraday increase of 62% Provided it continues to trade in this manner, we’ll be looking to take advantage of any similar swings to the ones we’ve seen already. We want to see it make higher lows, and break through the channel of resistance between the previous two sessions’ swing highs (.0128-.0139).


Side Note:

Even with so much else to talk about today, we can’t forget about another cash cow in Apple. AAPL Calls have been providing us with some excellent opportunities in recent weeks as well, and we’re still highly attuned to that situation as well.


Extended Watchlist:
DNAX, SPEX, AVNR, SGMS, ATEA, TPLM, KNDI